MAJI (Exousia Pro) Operating Margin %: 0.00% (As of Jan. 2021)


What is Exousia Pro Operating Margin %?

Exousia Pro MAJI +5.90% Operating Margin % is 0.00% as of Jan. 2021.

Operating Margin % is calculated as Operating Income divided by its Revenue. Exousia Pro's Operating Income for the three months ended in Jan. 2021 was $-0.13 Mil. Exousia Pro's Revenue for the three months ended in Jan. 2021 was $0.00 Mil. Therefore, Exousia Pro's Operating Margin % for the quarter that ended in Jan. 2021 was 0.00%.

The historical rank and industry rank for Exousia Pro's Operating Margin % or its related term are showing as below:


MAJI's Operating Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -86.83
* Ranked among companies with meaningful Operating Margin % only.

Exousia Pro's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Exousia Pro's Operating Income for the three months ended in Jan. 2021 was $-0.13 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jan. 2021 was $-0.55 Mil.


Exousia Pro  (OTCPK:MAJI) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Exousia Pro Operating Margin % Related Terms


Exousia Pro Operating Margin % Historical Data

* Premium members only.

The historical data trend for Exousia Pro's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Exousia Pro Operating Margin % Chart

Exousia Pro Annual Data
Trend Apr11 Apr12 Apr18 Apr19
Operating Margin %
0.00 0.00 0.00 0.00

Exousia Pro Quarterly Data
Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MAJI vs HCCH, GRNV, AGBA: Operating Margin % Comparison

For the Biotechnology subindustry, Exousia Pro's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Exousia Pro Operating Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Exousia Pro's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Exousia Pro's Operating Margin % falls into.



Exousia Pro Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Exousia Pro's Operating Margin % for the fiscal year that ended in Apr. 2019 is calculated as

Operating Margin %=Operating Income (A: Apr. 2019 ) / Revenue (A: Apr. 2019 )
=-0.125 / 0
= %

Exousia Pro's Operating Margin % for the quarter that ended in Jan. 2021 is calculated as

Operating Margin %=Operating Income (Q: Jan. 2021 ) / Revenue (Q: Jan. 2021 )
=-0.134 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 0.00% mean?
Exousia Pro (MAJI) has a Operating Margin % of 0.00% as of Jan. 2021. Operating margin is the ratio of total operating income to net sales. View historical data on Exousia Pro and its competitors.
Is Exousia Pro's Operating Margin % too high?
Exousia Pro's current Operating Margin % is 0.00%.
How does Exousia Pro's Operating Margin % compare to HCCH and GRNV?
Exousia Pro's Operating Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Exousia Pro and its competitors. Exousia Pro's current Operating Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Exousia Pro stock overvalued right now?
Exousia Pro (MAJI) has a current Operating Margin % of 0.00%. The current Operating Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Exousia Pro (MAJI), the current Operating Margin % is 0.00% as of Jan. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Exousia Pro Business Description

Address 7901 4th Street North, No. 23494, St. Petersburg, FL, USA, 33702
Exousia Pro Inc is a exosome-based biotechnology, develops and manufactures mammalian and plant-based exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells. The company is developing new ways to exploit the therapeutic potential of exosomes, initially focused in the field of oncology. The platform technology of the company also helps treating a broad spectrum of viral infections.